The U.S. Food and Drug Administration (FDA) wants to increase awareness about the intended use of imaging software for intracranial large vessel occlusion or LVO.
Read more: Intended Use of Imaging Software for Intracranial Large Vessel Occlusion - Letter to Health Care Providers